Applied Therapeutics Inc (NAS:APLT)

$ 4.54 0.1 (2.25%) Market Cap: 518.77 Mil Enterprise Value: 372.63 Mil PE Ratio: 0 PB Ratio: 7.71 GF Score: 39/100

Applied Therapeutics Inc Annual Shareholders Meeting Transcript
Jun 06, 2023
Applied Therapeutics Inc at Cowen Health Care Conference Transcript
Mar 08, 2023
Applied Therapeutics Inc at SVB Securities Global Biopharma Conference (Virtual) Transcript
Feb 16, 2023
Applied Therapeutics Inc Corporate Update Call Transcript
Feb 16, 2023
Applied Therapeutics Inc Annual Shareholders Meeting Transcript
Jun 02, 2022
Applied Therapeutics Inc at UBS Global Healthcare Virtual Conference Transcript
May 25, 2021
Eiger BioPharmaceuticals Inc, Applied Therapeutics, Ultragenyx Pharmaceutical, Dicerna Pharmaceuticals, and Imara Inc at Citi BioPharma Conference (Virtual) - Panel Transcript
Sep 09, 2020

Applied Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 06, 2023 / 02:00PM GMT

Release Date Price: $1.47 (+0.68%)

Transcript

Shoshana Shendelman

Applied Therapeutics, Inc. - CEO & Founder

Good morning, everyone. Welcome, and thank you for attending Applied Therapeutics Annual Meeting. I'm Dr. Shoshana Shendelman, Chair of the Board of Directors and CEO of Applied Therapeutics.

This year's Annual Meeting is being held in virtual meeting format. In the event that we encounter any technical difficulties, we ask that you please stand by and allow us time to provide an update regarding the meeting.

Joining us today by audio are my fellow directors: Les Funtleyder, Stacy Kanter, Teena Lerner, Joel Marcus, and Jay Skyler. In addition, joining us today are certain officers of Applied Therapeutics, including Dr. Riccardo Perfetti, our Chief Medical Officer; and Adam Hansard, our Chief Commercial Officer. Representatives from Ernst & Young LLP, the company's independent registered public accounting firm, have also joined us today. They will be available to answer appropriate questions during the meeting and answer session following the formal business of the meeting. Also present by audio is Karl Wagner, who

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.